Aug 5, 2009 - Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Depakote® (divalproex ER) 500mg Extended-release Tablets.
The details can be read here.
No comments:
Post a Comment